NASDAQ:IMVT

Immunovant Stock Forecast

etoro logo Buy IMVT
*Your capital is at risk
$39.89
-0.0600 (-0.150%)
At Close: Aug 10, 2026

Should you buy IMVT stock?

Last updated:

Based on market data through , StockInvest.us rates Immunovant, Inc. (IMVT) as a Buy Candidate with a technical score of 3.43 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Buy signal since
  • Price since signal Up 16.88%
  • 3-month trend forecast Up 36.41%
  • Buy Candidate 3.43
AI Analysis AI Analysis of IMVT AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add IMVT to Watchlist?
Some Reasons Why To Add IMVT:
  • +170.3% price growth over the last year
  • High gross margin of 97.1%
  • Low bankruptcy risk (Altman Z-Score: 38.09)
PDF

Red day on Monday for Immunovant, Inc. stock after losing 0.150%
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since May 21, 2026 Gain 16.88%

The Immunovant, Inc. stock price fell by -0.150% on the last day (Monday, 10th Aug 2026) from $39.95 to $39.89. During the last trading day the stock fluctuated 2.07% from a day low at $39.16 to a day high of $39.97. The price has fallen in 6 of the last 10 days and is down by -0.5% for this period. Volume has increased on the last day by 261 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $41.75 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 36.41% during the next 3 months and, with a 90% probability hold a price between $50.79 and $61.91 at the end of this 3-month period.

IMVT Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -2.92%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. The Immunovant, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $39.34 and $39.17. A breakdown below any of these levels will issue sell signals.

Support, Risk & Stop-loss for Immunovant, Inc. stock

Immunovant, Inc. finds support from accumulated volume at $38.85 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.81 between high and low, or 2.07%. For the last week the stock has had daily average volatility of 3.25%.

Our recommended stop-loss: $38.67 (-3.06%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 22 days ago.)

Trading Expectations (IMVT) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Immunovant, Inc. to open at $39.67, and during the day (based on 14 day Average True Range), to move between $39.16 and $40.62, which gives a possible trading interval of +/-$1.46 (+/-3.72%) up or down from last closing price. If Immunovant, Inc. takes out the full calculated possible swing range there will be an estimated 3.72% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $40.09 (0.50%) than the support at $38.85 (2.61%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Immunovant, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Immunovant, Inc. stock to perform well in the short-term.

Current score: 3.432 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $39.67 ( 0.543%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

IMVT Performance

Trading levels for IMVT

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 40.48 1.49%
R2 40.17 0.712%
R1 39.98 0.233%
Price 39.89
S1 39.36 -1.32%
S2 39.17 -1.80%
S3 38.86 -2.57%

Accumulated Volume Support & Resistance Levels

Level Price
R3 41.09 3.01%
R2 40.31 1.05%
R1 40.09 0.501%
Price 39.89
S1 38.85 -2.61%
S2 35.56 -10.85%
S3 34.13 -14.44%

FAQ

What is the symbol for Immunovant, Inc. Stock and on which exchange is it traded?
The symbol for Immunovant, Inc. is IMVT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Immunovant, Inc. Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Immunovant, Inc. (IMVT) as a Buy Candidate with a technical score of 3.43 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Buy signal began on May 21, 2026, the price has risen 16.88%. The current 3-month trend forecast projects a rise of 36.41%.

How to buy Immunovant, Inc. Stock?
Immunovant, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Immunovant, Inc. Stock.

What's the current price of Immunovant, Inc. Stock?
As of the end of day on the Aug 10, 2026, the price of an Immunovant, Inc. (IMVT) share was $39.89.

What is the 52-week high and low for Immunovant, Inc. Stock?
The 52-week high for Immunovant, Inc. Stock is $41.21 and the 52-week low is $14.32.

What is the market capitalization of Immunovant, Inc. Stock?
As of the Aug 10, 2026, the market capitalization of Immunovant, Inc. is 8.233B.
Click to get the best stock tips daily for free!
ABOUT IMMUNOVANT, INC.
Immunovant
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE